Hybrid Systems of Exosomes and Synthetic Nanocarriers in Breast Cancer Therapy: Bridging Natural and Synthetic Approaches

View at publisher Summarise with VIRAT
Authors: Pallavi Kumari, Anupama Aiyar, Shweta Dang
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Breast cancer therapy faces persistent challenges such as drug resistance, systemic toxicity, and limited targeting efficiency. Exosomes, with their intrinsic biocompatibility and ability to deliver biomolecules across biological barriers, offer unique advantages but are constrained by low yield and scalability issues. Synthetic nanocarriers, though versatile, often suffer from stability and safety limitations. This review aims to explore the integration of exosomes with synthetic nanocarriers to create hybrid delivery systems that combine natural targeting potential with enhanced drug loading, stability, and controlled release. The objective is to critically assess recent strategies for hybridization, functionalization, and therapeutic applications, while outlining key translational challenges and future prospects. Such hybrid systems hold promise as nextgeneration platforms for precise and effective breast cancer therapy.

Fields of Study & Subjects

Extracellular vesicles in disease Nanoparticle-Based Drug Delivery Nanoplatforms for cancer theranostics

Publication details

Journal / source
Current Pharmaceutical Design
Volume
32
Publication date
25 March 2026
Language
EN